About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials | 16,734 Studies Recruiting

Clinical TrialsBreast Cancer

Breast Cancer Clinical Trials

Browse 16,734 clinical trials for breast cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 961-980 of 16,734 trials

UnknownIdentification of Benign and Malignant Breast Nodules Using Ultrasound-modulated Optical Tomography: A Multicenter StudyUltrasonic light scattering imaging is a new functional imaging technology that combines traditional B-mode ultrasound imaging and light scattering tomography (DOT).NCT06468566·Wuhan, Hubei CompletedCetuximab + / - Carboplatin for Estrogen Receptor-Negative, Progesterone Receptor-Negative Metastatic Breast CancerRATIONALE: Monoclonal antibodies, such as cetuximab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread.NCT00232505·Birmingham, Alabama and 13 others

Related Searches

breast carcinomatrials

Data from ClinicalTrials.govTerms

CompletedContribution of 18FDG PET-Scan in Tumour Volume Determination in Patients Operated of Breast CancerUse of positron emission tomography (PET) in determination of functional tumour volume can provide usable information for radiotherapy to define the irradiated volume.NCT01621529·Rouen

RecruitingComparison Between Erector Spinae Plane Block Versus Serratus Anterior Plane Block Regarding Analgesia Post Modified Radical MastectomyThe goal of this clinical trial is to compare Ultrasound Guided Erector Spinae and Ultrasound Guided Serratus Anterior Plane Block post Modified Radical Mastectomy in adult…NCT06947330·Cairo, Waili

RecruitingSABER Study for Selected Early Stage Breast CancerThe purpose of this study is to find the most effective dose of radiation therapy to give to breast tumors in a shorter period of time, prior to standard partial…NCT04360330·Miami, Florida

RecruitingLymphBridge: Surgical Evaluation for Breast Cancer-Associated Lymphedema (BioBridge)To investigate whether the addition of Fibralign's BioBridge® Collagen Matrix (BioBridge) devices to the standard surgery for vascularized lymph node transfer will improve the…NCT04606030·Chicago, Illinois and 1 other

Not yet recruitingNeoAdjuvant Therapy Comparing Sacituzumab Govitecan+Pembrolizumab vs. SoC Chemotherapy in Clinical Stage II-III, Triple-negative Early Breast CancerTNBC is a heterogeneous disease with distinct pathological, genetic, and clinical features among subtypes.NCT07178730·Heilbronn, Baden-Wurttemberg and 25 others

RecruitingOmission of ALND in Breast Cancer Patients With Axillary pCRThis prospective, single-arm, phase II trial studies axillary lymph node dissection (ALND) to see if it can be safely omitted in breast cancer patients with axillary pathological…NCT05939830·Nanjing

TerminatedRO4929097 And Exemestane in Treating Pre- and Postmenopausal Patients With Advanced or Metastatic Breast CancerThis partially randomized phase I trial is studying the side effects and the best dose of RO4929097 when given together with exemestane and to see how well it works compared to…NCT01149356·Tampa, Florida and 3 others

RecruitingEffectiveness of an eHealth Self-management Support Program for Persistent Pain After Breast Cancer TreatmentThe scientific goals of the project are: 1.NCT06308029·Antwerp and 1 other

CompletedStudy to Evaluate Markers of Response in Locally Advanced Breast CancerThe purpose of this study is to compare the association between image and certain molecular markers with complete response in patients with locally advanced breast cancer, treated…NCT01338753·Teruel, Aragon and 10 others

Not yet recruitingPrimary Prevention of Thrombocytopenia Associated With T-DM1 Therapy in HER2 Positive Breast Cancer With HerombopagAdo-trastuzumab emtansine (T-DM1) demonstrates favorable efficacy in breast cancer treatment but is frequently associated with thrombocytopenia.NCT07198672

UnknownUse of Hair to Diagnose Breast CancerThis study aims to perform x-ray diffraction analysis of blinded hair samples from women with a documented health status, to validate the previous findings of James et al who…NCT00390377·Sydney, New South Wales

WithdrawnDynamics and Tracer Distribution of Tilmanocept in Early Stage Breast CancerA sentinel node procedure is recommended for patients with early stages of breast cancer to exclude metastases to local lymph nodes.NCT04487912·Ghent

Not yet recruitingA Trial to Evaluate Sacituzumab Govitecan in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Metastatic Breast Cancer Progressed on CDK4/6 InhibitorsSoGreat is an open-label, single-arm, modular, two-stage, Phase Ib/II study. SoGreat (Part 1) is an open-label, modular, Phase Ib study.NCT07163481·Changsha, Hunan

CompletedRuxolitinib W/ Preop Chemo For Triple Negative Inflammatory BrcaThis phase I/II research study is evaluating a combination of drugs called paclitaxel and ruxolitinib as a possible treatment for inflammatory breast cancer.NCT02041429·Boston, Massachusetts

CompletedXEBRA Study: An Observational Study of Xeloda (Capecitabine) in Combination With Docetaxel in First Line in Participants With HER2-Negative Metastatic Breast CancerThis multicenter observational study will evaluate the efficacy and safety of Xeloda (capecitabine) in combination with docetaxel in first-line therapy in participants with…NCT01777945·Budapest and 13 others

RecruitingA Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, and therapeutic activity of GI-102 as a single agent and in combination with conventional…NCT05824975·Scottsdale, Arizona and 10 others

Not yet recruitingBRain-AVOidant Proton Craniospinal Irradiation for Leptomeningeal Metastases From Solid Tumor MalignanciesThe purpose of this study is to determine the efficacy of BRain-AVOidant proton craniospinal irradiation (BRAVO pCSI) in adult participants with leptomeningeal metastases from…NCT07789912·Miami, Florida

CompletedTrastuzumab and Trastuzumab-MCC-DM1 Administered Intravenously and GDC-0941 Administered Orally to Patients With HER2-Positive Metastatic Breast Cancer Who Have Progressed on Previous Trastuzumab-Based TherapyThis multicenter, Phase Ib study is an open label, dose escalation, three-arm study evaluating the safety, tolerability, pharmacokinetics, and activity of oral (PO) GDC 0941…NCT00928330·Indianapolis, Indiana and 2 others

PreviousPage 49 of 837Next